{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"early-onset-lafora-body-disease","columns":[{"gene":"","key":"population-09740b199fab4a70ad39","label":"Epilepsy, progressive myoclonic, 10","mondoId":"MONDO:0014717","onsetQualifier":null,"originColumnKey":"MONDO:0014717/OMIM:616640","originalViews":[{"key":"MONDO:0014717/OMIM:616640","label":"Epilepsy, progressive myoclonic, 10","scopeLabel":"OMIM:616640","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["066a0e351404be20db1c585c11a61ba99f05426f1aac192c6140f9552ba3fe28","0e4c48fbbc548527826e7d77904d45865058b5520a98b6d213434cbf533bb026","1927bfb25050647a83f5e0553b393c96f91500eb5f04c0e62216735d3226df93","1d7660c47466215deb1abdaccf0864e46b9b7df7c581bc060595c53b1f673cea","22eb4bb9585605b8cf024d47cd7a9b69b15aa1e5329660497f652fbef771f34d","3a45d83487a67e16a13b72ba747a52d0787fb22cb7eb6271c4aa134b45d04eda","4ef07c583d06ab4aa5bdb8c703b22de3eedeaba6f7be39267b1c42c6eb48ad64","680ab0d8e2937bba49a2a5f1fcfa4dddb6b61970cb362bd2283d05c607e26a12","77fb21de4dd2eb892ffe0f504a3fcf32f581e1c272f77ad57e011fb1a19b318a","7e24f880ce47257522e37dad5c68ef7275edfdb03f58cb83170c9d4dffcb8bcf","b25c8592c106425ad643c6a2c78d9479ef7b9c434c31c52e5a85cbe616009edb","b4d1a9dee12c7957a65d4d14021f1a30a035792c3952802f6b3990e6754fdba4","c1519e996840c748cfb6f0e9888e52780f02d1a2f5e4dd4b960921dc7e4c459d","ca92a46b69ddb26234cd94deaf5b4b3970b81460b62101156276d83197b6807d","e3b78b98934423041d00a474f211bc647ba7872c69ec8f1b0e83470e50251d70","e485b648779234296dfcbcd33b020e87ad7e4642fc81374e7fffc9e75a014e4d","e9a830fdd39d0440ffa40e83fff0e0d9b89b95ce4356a6841cb3a1283eb39940","f483c08793f2d1251c540b8f4f3bf68b404f87cb76a0869187a607c486354ed8"],"recordQualifiers":{},"scopeLabel":"OMIM:616640","sourceIds":["OMIM:616640"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-297c41758156b1f19cbc","label":"PRDM8-related progressive myoclonus epilepsy","mondoId":"MONDO:0014717","onsetQualifier":null,"originColumnKey":"MONDO:0014717/ORPHA:324290","originalViews":[{"key":"MONDO:0014717/ORPHA:324290","label":"PRDM8-related progressive myoclonus epilepsy","scopeLabel":"ORPHA:324290","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["07087a7f7f6833c11e03118ff0b6b9a6d6f40e64ed58ebecd45fa66140714f54","117044a80594293ffb5670801188201a661bda84eb928ba262be787973ac27fa","1a57f90a1e3feef9032429f012d037cd58a63eebdb9babda6dba61b3a55d75e0","216809b8f3a53dca2b8e5cb2dcda389904a3615a2d98e61250dc06556501c339","41176e95c14f0a90e424ecb21a166e9a2a2c9774dcd69ad09b532b1e67eb7b6d","41f58d9911d4bfa894ea24e3501033ddb13ba2fbb15a58fbe4cc11280f428fa9","7561b9fb8a00f7b2b454ee3ebbfe73e654ec0dfa42ebc7319fcacfa25fbc1f99","9ffd60b1e1fe2791ff08c9117a02f49e1af2a7558f408446a31f95b4a1183962","a7945df81e45dc4b765b1a4fd29212e99145c4c414f9fb5c06e5d213ab414767","cb8493790134f5b8ab47887c1d835eb2e0108eab4daead66492e6d6ef4b32a3a","cc67ad77356ca319d81a8472e196ca41a4696e61245c29f55da80d4b39d0b4c7","e83c5e8e68da8e712016e7b6f72bab211f699126be96779921172c0abf0a5bad"],"recordQualifiers":{},"scopeLabel":"ORPHA:324290","sourceIds":["ORPHA:324290"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-09740b199fab4a70ad39","population-297c41758156b1f19cbc"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001251","HP:0000708","HP:0100543","HP:0001289","HP:0000726","HP:0001260","HP:0002123"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":30,"sourceGroups":{"omim":5,"orphanet":12,"published":13}},"features":[{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0000708","label":"Atypical behavior","primary":true},{"hpoId":"HP:0100543","label":"Cognitive impairment","primary":true},{"hpoId":"HP:0001289","label":"Confusion","primary":true},{"hpoId":"HP:0000726","label":"Dementia","primary":true},{"hpoId":"HP:0001260","label":"Dysarthria","primary":true},{"hpoId":"HP:0002123","label":"Generalized myoclonic seizure","primary":true},{"hpoId":"HP:0000738","label":"Hallucinations","primary":false},{"hpoId":"HP:0001347","label":"Hyperreflexia","primary":false},{"hpoId":"HP:0100318","label":"Lafora bodies","primary":false},{"hpoId":"HP:0001268","label":"Mental deterioration","primary":false},{"hpoId":"HP:0002300","label":"Mutism","primary":false},{"hpoId":"HP:0001336","label":"Myoclonus","primary":false},{"hpoId":"HP:0011999","label":"Paranoia","primary":false},{"hpoId":"HP:0002073","label":"Progressive cerebellar ataxia","primary":false},{"hpoId":"HP:0000709","label":"Psychosis","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0002497","label":"Spastic ataxia","primary":false},{"hpoId":"HP:0001285","label":"Spastic tetraparesis","primary":false},{"hpoId":"HP:0002510","label":"Spastic tetraplegia","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0000020","label":"Urinary incontinence","primary":false}],"ledeHtml":"A rare genetic progressive myoclonic epilepsy characterized by childhood onset of progressive dysarthria, myoclonus, ataxia, seizures, and cognitive decline. The disease takes a protracted course with patients surviving into adulthood, developing signs and symptoms like psychosis with outbursts of prolonged agitation and screaming, spasticity and hyperreflexia, confusion, mutism, and incontinence. There are no visual disturbances. Muscle biopsy shows numerous periodic acid-Schiff-positive inclusions, so-called Lafora bodies.","mondoId":"MONDO:0014717","node":{"canonicalSlug":"early-onset-lafora-body-disease","comparisons":[{"documentSha256":"633f755e27ac01c88f65d0858a623718bd83997318441351b93daf1ba7028438","key":"legacy-early-onset-lafora-body-disease","kind":"legacy","label":"early-onset Lafora body disease","memberIds":["MONDO:0014717"],"mondoId":"MONDO:0014717","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/early-onset-lafora-body-disease.633f755e27ac01c88f65d0858a623718bd83997318441351b93daf1ba7028438.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Early-onset Lafora body disease","originalSourceId":"ORPHA:324290","paragraphs":["A rare genetic progressive myoclonic epilepsy characterized by childhood onset of progressive dysarthria, myoclonus, ataxia, seizures, and cognitive decline. The disease takes a protracted course with patients surviving into adulthood, developing signs and symptoms like psychosis with outbursts of prolonged agitation and screaming, spasticity and hyperreflexia, confusion, mutism, and incontinence. There are no visual disturbances. Muscle biopsy shows numerous periodic acid-Schiff-positive inclusions, so-called Lafora bodies."],"rawAttribution":"MONDO:0014717","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:02:33Z","upstream":"MONDO:0014717","url":"https://rarediseases.info.nih.gov/diseases/17482"},"ownColumnKeys":["population-09740b199fab4a70ad39","population-297c41758156b1f19cbc"],"publication":"published","relationships":[{"kind":"parent","label":"progressive myoclonus epilepsy","mondoId":"MONDO:0020074","slug":"progressive-myoclonus-epilepsy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"066a0e351404be20db1c585c11a61ba99f05426f1aac192c6140f9552ba3fe28","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"07087a7f7f6833c11e03118ff0b6b9a6d6f40e64ed58ebecd45fa66140714f54","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324290","disease_name":"PRDM8-related progressive myoclonus epilepsy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001268","is_excluded":false,"label":"Mental deterioration","onset_id":null,"reference":"ORPHA:324290","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"0e4c48fbbc548527826e7d77904d45865058b5520a98b6d213434cbf533bb026","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000020","is_excluded":false,"label":"Urinary incontinence","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"117044a80594293ffb5670801188201a661bda84eb928ba262be787973ac27fa","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324290","disease_name":"PRDM8-related progressive myoclonus epilepsy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002300","is_excluded":false,"label":"Mutism","onset_id":null,"reference":"ORPHA:324290","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"1927bfb25050647a83f5e0553b393c96f91500eb5f04c0e62216735d3226df93","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002510","is_excluded":false,"label":"Spastic tetraplegia","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"1a57f90a1e3feef9032429f012d037cd58a63eebdb9babda6dba61b3a55d75e0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324290","disease_name":"PRDM8-related progressive myoclonus epilepsy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100318","is_excluded":false,"label":"Lafora bodies","onset_id":null,"reference":"ORPHA:324290","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"1d7660c47466215deb1abdaccf0864e46b9b7df7c581bc060595c53b1f673cea","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000709","is_excluded":false,"label":"Psychosis","onset_id":null,"reference":"OMIM:616640","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"216809b8f3a53dca2b8e5cb2dcda389904a3615a2d98e61250dc06556501c339","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324290","disease_name":"PRDM8-related progressive myoclonus epilepsy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000708","is_excluded":false,"label":"Atypical behavior","onset_id":null,"reference":"ORPHA:324290","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"22eb4bb9585605b8cf024d47cd7a9b69b15aa1e5329660497f652fbef771f34d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000726","is_excluded":false,"label":"Dementia","onset_id":null,"reference":"OMIM:616640","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"3a45d83487a67e16a13b72ba747a52d0787fb22cb7eb6271c4aa134b45d04eda","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0100318","is_excluded":false,"label":"Lafora bodies","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"41176e95c14f0a90e424ecb21a166e9a2a2c9774dcd69ad09b532b1e67eb7b6d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324290","disease_name":"PRDM8-related progressive myoclonus epilepsy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001289","is_excluded":false,"label":"Confusion","onset_id":null,"reference":"ORPHA:324290","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"41f58d9911d4bfa894ea24e3501033ddb13ba2fbb15a58fbe4cc11280f428fa9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324290","disease_name":"PRDM8-related progressive myoclonus epilepsy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001285","is_excluded":false,"label":"Spastic tetraparesis","onset_id":null,"reference":"ORPHA:324290","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"4ef07c583d06ab4aa5bdb8c703b22de3eedeaba6f7be39267b1c42c6eb48ad64","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"680ab0d8e2937bba49a2a5f1fcfa4dddb6b61970cb362bd2283d05c607e26a12","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0100543","is_excluded":false,"label":"Cognitive impairment","onset_id":null,"reference":"OMIM:616640","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"7561b9fb8a00f7b2b454ee3ebbfe73e654ec0dfa42ebc7319fcacfa25fbc1f99","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324290","disease_name":"PRDM8-related progressive myoclonus epilepsy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001347","is_excluded":false,"label":"Hyperreflexia","onset_id":null,"reference":"ORPHA:324290","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"77fb21de4dd2eb892ffe0f504a3fcf32f581e1c272f77ad57e011fb1a19b318a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001347","is_excluded":false,"label":"Hyperreflexia","onset_id":null,"reference":"OMIM:616640","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7e24f880ce47257522e37dad5c68ef7275edfdb03f58cb83170c9d4dffcb8bcf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002123","is_excluded":false,"label":"Generalized myoclonic seizure","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"9ffd60b1e1fe2791ff08c9117a02f49e1af2a7558f408446a31f95b4a1183962","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324290","disease_name":"PRDM8-related progressive myoclonus epilepsy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001336","is_excluded":false,"label":"Myoclonus","onset_id":null,"reference":"ORPHA:324290","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a7945df81e45dc4b765b1a4fd29212e99145c4c414f9fb5c06e5d213ab414767","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324290","disease_name":"PRDM8-related progressive myoclonus epilepsy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:324290","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b25c8592c106425ad643c6a2c78d9479ef7b9c434c31c52e5a85cbe616009edb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"b4d1a9dee12c7957a65d4d14021f1a30a035792c3952802f6b3990e6754fdba4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001336","is_excluded":false,"label":"Myoclonus","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c1519e996840c748cfb6f0e9888e52780f02d1a2f5e4dd4b960921dc7e4c459d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002073","is_excluded":false,"label":"Progressive cerebellar ataxia","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ca92a46b69ddb26234cd94deaf5b4b3970b81460b62101156276d83197b6807d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"cb8493790134f5b8ab47887c1d835eb2e0108eab4daead66492e6d6ef4b32a3a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324290","disease_name":"PRDM8-related progressive myoclonus epilepsy","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0011999","is_excluded":false,"label":"Paranoia","onset_id":null,"reference":"ORPHA:324290","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cc67ad77356ca319d81a8472e196ca41a4696e61245c29f55da80d4b39d0b4c7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324290","disease_name":"PRDM8-related progressive myoclonus epilepsy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:324290","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e3b78b98934423041d00a474f211bc647ba7872c69ec8f1b0e83470e50251d70","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002300","is_excluded":false,"label":"Mutism","onset_id":null,"reference":"OMIM:616640","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e485b648779234296dfcbcd33b020e87ad7e4642fc81374e7fffc9e75a014e4d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000738","is_excluded":false,"label":"Hallucinations","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"e83c5e8e68da8e712016e7b6f72bab211f699126be96779921172c0abf0a5bad","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324290","disease_name":"PRDM8-related progressive myoclonus epilepsy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"ORPHA:324290","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e9a830fdd39d0440ffa40e83fff0e0d9b89b95ce4356a6841cb3a1283eb39940","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002497","is_excluded":false,"label":"Spastic ataxia","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"f483c08793f2d1251c540b8f4f3bf68b404f87cb76a0869187a607c486354ed8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616640","disease_name":"Epilepsy, progressive myoclonic, 10","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0011999","is_excluded":false,"label":"Paranoia","onset_id":null,"reference":"PMID:22961547","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17482\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014717\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0014717</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare genetic progressive myoclonic epilepsy characterized by childhood onset of progressive dysarthria, myoclonus, ataxia, seizures, and cognitive decline. The disease takes a protracted course with patients surviving into adulthood, developing signs and symptoms like psychosis with outbursts of prolonged agitation and screaming, spasticity and hyperreflexia, confusion, mutism, and incontinence. There are no visual disturbances. Muscle biopsy shows numerous periodic acid-Schiff-positive inclusions, so-called Lafora bodies.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17482\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"early-onset-lafora-body-disease","sourceDocuments":[{"name":"GARD: Early-onset Lafora body disease","reviewed":null,"source_release":"2026-10-21T17:02:33Z","url":"https://rarediseases.info.nih.gov/diseases/17482"},{"name":"MONDO: early-onset Lafora body disease","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014717"}],"sourceNote":"","synonyms":["epilepsy, progressive myoclonic, 10","epilepsy, progressive myoclonic, type 10","EPM10"],"takeawayHtml":"","title":"early-onset Lafora body disease"},"schemaVersion":1}
